Penn Medicine Provider
Family Medicine
Jacqueline Deanna Wilson, MD, MPH
Accepting new patients
Sees patients age 18 and up
Penn Family Care

About me

  • Presidential Assistant Professor
  • Assistant Professor of Pediatrics

Education and training

  • Medical School: Yale University
  • Residency: Johns Hopkins Hospital
  • Fellowship: Johns Hopkins Hospital

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Wilson is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Wilson JD, Klipp SP, Leon K, Liebschutz JM, Merlin J, Murray-Krezan C, Nolette S, Phillips KT, Stein M, Weinstock N, Hamm M. "To not feel fake, it can't be fake": co-creation of a harm reduction, peer-delivered, health-system intervention for people who use drugs. , Harm Reduct J: 2025


Leon K, Weger R, Weinstock N, Jawa R, Wilson JD. "It's nothing personal": understanding barriers to relational harm reduction practices during inpatient hospitalization. , Harm Reduct J.: 2025


Salay M, Edwards KA, Winstanley EL, Bachrach RL, Bulls HW, Hanmer J, Liebschutz JM, Robbins J, Wilson JD, Yu L, Merlin JS, Murray-Krezan C. Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial , Subst Use Addctn J: 2025


Hamm M, Wilson JD, Lee YJ, Norman N, Winstanley EL, McTigue KM. Substance use as subtext to health narratives: Identifying opportunities for improving carefrom community member perspectives. , Patient Educ Couns. : 2024


Weger R, Weinstock N, Jawa R, Wilson JD. "We're Not Gonna Aid You in Shooting Up": Stigma's Relationship to Harm Reduction in People Who Inject Drugs. , J Gen Intern Med.: 2024


O'Brien C, Klipp S, Jawa R, Wilson JD Community pharmacists' attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey. , Harm Reduct J, 21(1): 2024


Rider-Longmaid E, Wilson JD. Ushering in a New Paradigm of Substance Use Prevention-Low-Touch Personalized Interventions in Specialty Care , JAMA Netw Open, 7(7): 2024


Lim G, Xue L, Donohue JM, Junker S, Wilson JD, Suffoletto B, Lynch MJ, Pacella-LaBarbara ML, Chang CH, Krans E, Jarlenski M. Associations between acute pain after vaginal delivery and postpartum opioid prescription fills: a retrospective case-controlled study. , Br J Anaesth.: 2024


Herrera MC, Johnson J, Lim S, Morales KH, Wilson JD, Hadland SE, Metzger D, Wood S, Dowshen N. Co-delivery of HIV pre-exposure prophylaxis (PrEP) and HIV testing among publicly insured adolescents and young adults (AYA) receiving medication for opioid use disorder (MOUD). , Drug Alcohol Depend.: 2024


Green E, Hamm M, Gowl C, Van Deusen R, Liebschutz JM, Wilson JD, Merlin J. Optimizing evidence-based practice implementation: a case study on simulated patient protocols in long-term opioid therapy. , Implement Sci Commun., 5(1): 2024